Sanara MedTech (SMTI) Net Income towards Common Stockholders (2016 - 2025)
Sanara MedTech's Net Income towards Common Stockholders history spans 15 years, with the latest figure at -$502848.0 for Q4 2025.
- For Q4 2025, Net Income towards Common Stockholders rose 80.92% year-over-year to -$502848.0; the TTM value through Dec 2025 reached -$37.0 million, down 362.82%, while the annual FY2025 figure was -$37.2 million, 366.18% down from the prior year.
- Net Income towards Common Stockholders reached -$502848.0 in Q4 2025 per SMTI's latest filing, up from -$31.2 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$23544.0 in Q3 2024 to a low of -$31.2 million in Q3 2025.
- Average Net Income towards Common Stockholders over 5 years is -$3.5 million, with a median of -$1.8 million recorded in 2023.
- Peak YoY movement for Net Income towards Common Stockholders: surged 97.85% in 2024, then crashed 132615.77% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$3.5 million in 2021, then dropped by 17.34% to -$4.2 million in 2022, then soared by 93.7% to -$262444.0 in 2023, then plummeted by 904.14% to -$2.6 million in 2024, then skyrocketed by 80.92% to -$502848.0 in 2025.
- Per Business Quant, the three most recent readings for SMTI's Net Income towards Common Stockholders are -$502848.0 (Q4 2025), -$31.2 million (Q3 2025), and -$1.8 million (Q2 2025).